Alterity Therapeutics
ATHE
10 hedge funds and large institutions have $181K invested in Alterity Therapeutics in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 10 → 10 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
30% less capital invested
Capital invested by funds: $257K → $181K (-$76K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$13.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.07K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$69 |
| 4 |
JP Morgan Chase
New York
|
+$69 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
-$39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $170K | +$13.8K | +2,010 | +8% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $7K | – | – | – |
|
3
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | +$2.07K | +301 | +4,300% |
|
|
APA
5
American Portfolios Advisors
Holbrook,
New York
| $50 | – | – | – |
|
|
EP
6
Eudaimonia Partners
Winchester,
Tennessee
| – | -$39K | -5,000 | Closed |
|
|
7
Bank of America
Charlotte,
North Carolina
| – | +$69 | +10 | New |
|
|
8
JP Morgan Chase
New York
| – | +$69 | +10 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| – | +$165 | +24 | New |
|
ATHE Hedge Fund Activity: Q1 2020 in Review
10 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2020, worth a combined $181K — down 30% from $257K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ATHE positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $13.8K. The largest seller was Eudaimonia Partners, exiting entirely with an estimated $39K sold.
- 10 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $181K of Alterity Therapeutics stock for Q1 2020, down 30% quarter-over-quarter.
- 3 funds opened new Alterity Therapeutics positions in Q1 2020 and 2 closed out, a net change of +1 holder.
- The largest Alterity Therapeutics buyer in Q1 2020 was Morgan Stanley, an estimated $13.8K added.
- The largest Alterity Therapeutics seller in Q1 2020 was Eudaimonia Partners, an estimated $39K sold.
Based on aggregated 13F filings for Q1 2020.